Answers are grounded in this paper and cite their sources.
Given increased knowledge from molecular biology and pharmacology, it is apparent that multiple factors can interact to produce clinically meaningful differences in a drug's effect in specific individuals (i.e., personalized medicine). This topic is discussed in this column using iloperidone as an example. The variables discussed include dose, dosing schedule, genes, drug-drug interactions, and other medical factors. How such variables can combine to alter a drug's effect is illustrated with a case example and the results of a thorough QTc study of iloperidone.
No takes yet. Share an insight, caveat, or question.
Sheldon Preskorn (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: